Because IFI44L was sufficient to distinguish AGS from hospitalized controls (often with concurrent infection), we hypothesize that the chronic inflammation associated with genetic interferonopathies may lead to a preferential upregulation of IFI44L. The gene discussed is IFI44L; the disease is Aicardi-Goutieres syndrome.